Centogene
Ellen Karges, MS, currently serves as the Executive Vice President of Quality and Regulatory Affairs at SAFE Health since June 2022. Karges also holds the title of Vice President of Pharmaceutical Compliance at Centogene AG, a position maintained since February 2019, and previously served as Senior Vice President of Pharmaceutical Compliance at the same company. In addition, Karges has been a Senior Director of Quality and a member of Extended Management at Centogene AG since September 2012, overseeing the development of the quality system and achieving various accreditations, including CAP/CLIA and ISO 15189. Prior to these roles, Karges was the Senior Vice President of Global Quality and Regulatory Affairs at Discovery Life Sciences from June 2020 to May 2022 and served as Operations Manager at Colorado GI Pathology from April 2006 to April 2009. Karges is recognized for strengths in leadership, project management, and mentoring.
This person is not in any offices
Centogene
2 followers
Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human genetics analysis. It develops a rare disease platform based on its real-world data repository with over 2.0 billion weighted data points from over 450, 000 patients representing around 115 different, which includes epidemiologic, phenotypic and genetic data that reflects a global population, as well as a biobank of patients' blood samples. In addition, it is active in the research and development products for human genetics. The Company operates in Germany and the United States.